Psychotropic drug prescriptions in Western European nursing homes

International Psychogeriatrics

Volumn 28, Issue 11, 2016, Pages 1775-1790

  Janus, Sarah I M ^a   Van Manen, Jeannette G ^a   Ijzerman, Maarten J ^a   Zuidema, Sytse U ^b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

dementia; nursing homes; psychopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AUSTRIA; BELGIUM; DATA ANALYSIS; DEMENTIA; DRUG USE; FRANCE; HUMAN; IRELAND; MEDICAL LITERATURE; MENTAL HEALTH SERVICE; NURSING HOME; OUTCOME ASSESSMENT; PRESCRIPTION; REVIEW; SWEDEN; CULTURAL FACTOR; EUROPE; HOME FOR THE AGED; INAPPROPRIATE PRESCRIBING; POTENTIALLY INAPPROPRIATE MEDICATION; STATISTICS AND NUMERICAL DATA;

CROSS-CULTURAL COMPARISON; DEMENTIA; EUROPE; HOMES FOR THE AGED; HUMANS; INAPPROPRIATE PRESCRIBING; NURSING HOMES; POTENTIALLY INAPPROPRIATE MEDICATION LIST; PSYCHOTROPIC DRUGS;

EID: 84980383504     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610216001150     Document Type: Review

References (63)

1. Azermai, M., Petrovic, M., Elseviers, M. M., Bourgeois, J., Van Bortel, L. M. and Vander Stichele, R. H. (2012). Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Research Reviews, 11, 78-86. doi: 10. 1016/j. arr. 2011. 07. 002.
2. Ballard, C., Corbett, A., Chitramohan, R. and Aarsland, D. (2009). Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions. Current Opinion in Psychiatry, 22, 532-540. doi: 10. 1097/YCO. 0b013e32833111f9.
3. Ballard, C., Creese, B., Corbett, A. and Aarsland, D. (2010). Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opinion on Drug Safety, 10, 35-43. doi: 10. 1517/14740338. 2010. 506711.
4. Banerjee, S. (2009). The Use of Antipsychotic Medication for People with Dementia: Time for Action. London: Department of Health.
5. Barca, M., Engedal, K., Laks, J. and Selbaek, G. (2010). A 12 months follow-up study of depression among nursing-home patients in Norway. Journal of Affective Disorders, 120, 141-148. doi: 10. 1016/j. jad. 2009. 04. 028.
6. Barendregt, J. J., Doi, S. A., Lee, Y. Y., Norman, R. E. and Vos, T. (2013). Meta-analysis of prevalence. Journal of Epidemiology and Community Health, 67, 974-978. doi: 10. 1136/jech-2013-203104.
7. Barry, H., Parsons, C., Passmore, A. and Hughes, C. (2015). Pain in care home residents with dementia: an exploration of frequency, prescribing and relatives' perspectives. International Journal of Geriatric Psychiatry, 30, 55-63. doi: 10. 1002/gps. 4111.
8. Bergh, S., Engedal, K., Røen, I. and Selbæk, G. (2011). The course of neuropsychiatric symptoms in patients with dementia in Norwegian nursing homes. International Psychogeriatrics, 23, 1231-1239. doi: 10. 1017/S1041610211001177.
9. Borza, T., Engedal, K., Bergh, S., Barca, M. L., Benth, J. Š. and Selbæk, G. (2015). The course of depressive symptoms as measured by the Cornell scale for depression in dementia over 74 months in 1158 nursing home residents. Journal of Affective Disorders, 175, 209-216. doi: 10. 1016/j. jad. 2014. 12. 053.
10. Bourgeois, J., Elseviers, M. M., Azermai, M., Van Bortel, L., Petrovic, M. and Vander Stichele, R. R. (2012). Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. European Journal of Clinical Pharmacology, 68, 833-844. doi: 10. 1007/s00228-011-1188-z.
11. Brodaty, H. and Arasaratnam, C. (2012). Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. American Journal of Psychiatry, 169, 946-953. doi: 10. 1176/appi. ajp. 2012. 11101529.
12. Cool, C. et al. (2014). Potentially inappropriate drug prescribing and associated factors in nursing homes. Journal of the American Medical Directors Association, 15, 3. doi: 10. 1016/j. jamda. 2014. 08. 003.
13. de Mauleon, A. et al. (2014). Associated factors with antipsychotic use in long-term institutional care in eight European countries: results from the RightTimePlaceCare study. Journal of the American Medical Directors Association, 15, 812-818. doi: 10. 1016/j. jamda. 2014. 06. 015.
14. Eggermont, L., de Vries, K. and Scherder, E. (2009). Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia. International Psychogeriatrics, 21, 286-294. doi: 10. 1017/S1041610209008552.
15. European Medicines Agency. (2008). Opinion of the Committee for medicinal products for human use pursuant to article 5(3) of regulation (EC) No 726/2004, on conventional antipsychotics. Available at: www. ema. europa. eu/docs/en-GB/document-library/Other/ 2010/01/WC500054056. pdf; last accessed 20 December 2015.
16. Fialová, D. et al. (2005). Potentially inappropriate medication use among elderly home care patients in Europe. JAMA, 293, 1348-1358. doi: 10. 1001/jama. 293. 11. 1348.
17. Foebel, A. et al. (2014). Use of antipsychotic drugs among residents with dementia in European long-term care facilities: results from the SHELTER study. Journal of the American Medical Directors Association, 15, 911-917. doi: 10. 1016/j. jamda. 2014. 07. 012.
18. Gallini, A., Andrieu, S., Donohue, J. M., Oumouhou, N., Lapeyre-Mestre, M. and Gardette, V. (2014). Trends in use of antipsychotics in elderly patients with dementia: impact of national safety warnings. European Neuropsychopharmacology, 24, 95-104. doi: 10. 1016/j. euroneuro. 2013. 09. 003.
19. Gauthier, S. et al. (2010). Management of behavioral problems in Alzheimer's disease. International Psychogeriatrics, 22, 346-372. doi: 10. 1017/S1041610209991505.
20. Gustafsson, M., Karlsson, S. and Lovheim, H. (2013). Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacology and Toxicology, 14, 10. doi: 10. 1186/2050-6511-14-10.
21. Gustafsson, M., Sandman, P., Karlsson, S., Gustafson, Y. and Lövheim, H. (2013). Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings. International Psychogeriatrics, 25, 1415-1423. doi: 10. 1017/S1041610213000859.
22. Harding, R. and Peel, E. (2013). 'He was like a zombie': off-label prescription of antipsychotic drugs in dementia. Medical law review, 21, 243-277. doi: 10. 1093/medlaw/fws029.
23. Helvik, A., Engedal, K., Benth, J. and Selbæk, G. (2014). A 52 month follow-up of functional decline in nursing home residents-degree of dementia contributes. BMC Geriatrics, 14, 1-10. doi: 10. 1186/1471-2318-14-45.
24. Hoffmann, F., Kaduszkiewicz, H., Glaeske, G., van den Bussche, H. and Koller, D. (2014). Prevalence of dementia in nursing home and community-dwelling older adults in Germany. Aging Clinical and Experimental Research, 26, 555-559. doi: 10. 1007/s40520-014-0210-6.
25. Houttekier, D. et al. (2010). Place of death of older persons with dementia. A study in five European countries. Journal of the American Geriatrics Society, 58, 751-756. doi: 10. 1111/j. 1532-5415. 2010. 02771. x.
26. Hundertmark, G. (2013). Prävalenz und Diagnosebezug von Psychopharmaka bei Patienten in Einrichtungen der stationären Altenpflege. Hamburg: Medizinischen Fakultät der Universität Hamburg.
27. Husebo, B., Ballard, C., Sandvik, R., Nilsen, O. and Aarsland, D. (2011). Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. [Journal Article]. British Medical Journal, 343. doi: 10. 1136/bmj. d4065.
28. Iden, K., Engedal, K., Hjorleifsson, S. and Ruths, S. (2014). Prevalence of depression among recently admitted long-term care patients in Norwegian nursing homes: associations with diagnostic workup and use of antidepressants. Dementia and Geriatric Cognitive Disorders, 37, 154-162. doi: 10. 1159/000355427.
29. Janssen-Cilag GmbH. (2004). Risperdal-Änderung der Produktinformation. Rote-Hand-Brief vom März 2004.
30. Available at: http://www. akdae. de/Arzneimittelsicherheit/ RHB/Archiv/2004/84-20040308. pdf; last accessed 20 December 2015.
31. Johnell, K. and Fastbom, J. (2012). Comparison of prescription drug use between community-dwelling and institutionalized elderly in Sweden. [Article]. Drugs & aging, 29, 751-758. doi: 10. 1007/s40266-012-0002-7.
32. Kleijer, B. et al. (2014). Variability between nursing homes in prevalence of antipsychotic use in patients with dementia. International Psychogeriatrics, 26, 363-371. doi: 10. 1017/S1041610213002019.
33. Kuske, B. et al. (2009). Training in dementia care: a cluster-randomized controlled trial of a training program for nursing home staff in Germany. International Psychogeriatrics, 21, 295-308. doi: 10. 1017/S1041610208008387.
34. Laffon de Mazieres, C., Lapeyre-Mestre, M., Vellas, B., de Souto Barreto, P. and Rolland, Y. (2015). Organizational factors associated with inappropriate neuroleptic drug prescribing in nursing homes: a multilevel approach. Journal of the American Medical Directors Association, 16, 590-597. doi: 10. 1016/j. jamda. 2015. 01. 092.
35. Lilly Pharma. (2004). Wichtige Information zu Olanzapin und zum Mortalitäts-und Schlaganfallrisiko bei älteren Patienten mit Demenz-assoziierter Psychose und/oder Verhaltensstörungen. Available at: http://www. akdae. de/Arzneimittelsicherheit/RHB/Archiv/ 2004/85-20040308. pdf; last accessed 18 December 2015.
36. Lithgow, S., Jackson, G. and Browne, D. (2012). Estimating the prevalence of dementia: cognitive screening in Glasgow nursing homes. International journal of geriatric psychiatry, 27, 785-791. doi: 10. 1002/gps. 2784.
37. Majic, T. et al. (2010). The pharmacotherapy of neuropsychiatric symptoms of dementia: a cross-sectional study in 18 homes for the elderly in Berlin. Deutsches Ärzteblatt International, 107, 320. doi: 10. 3238/arztebl. 2010. 0320.
38. McCleery, J. and Fox, R. (2012). Antipsychotic prescribing in nursing homes. British Medical Journal, 344. doi: 10. 1136/bmj. e1093.
39. Midlov, P., Andersson, M., Ostgren, C. J. andMolstad, S. (2014). Depression and use of antidepressants in Swedish nursing homes: a 12-month follow-up study. International Psychogeriatrics, 26, 669-675. doi: 10. 1017/S1041610213002354.
40. Mjørud, M., Røsvik, J., Rokstad, A., Kirkevold, M. and Engedal, K. (2014). Variables associated with change in quality of life among persons with dementia in nursing homes: a 10 months follow-up study. Plos One, 9, e115248. doi: 10. 1371/journal. pone. 0115248.
41. Olazaran, J., Valle, D., Serra, J. A., Cano, P. and Muniz, R. (2013). Psychotropic medications and falls in nursing homes: a cross-sectional study. Journal of the American Medical Directors Association, 14, 213-217. doi: 10. 1016/j. jamda. 2012. 10. 020.
42. Onder, G. et al. (2012). Assessment of nursing home residents in Europe: the services and health for elderly in long TERm care (SHELTER) study. BMC Health Services Research, 12, 1472-6963. doi: 10. 1186/1472-6963-12-5.
43. Pitkala, K. et al. (2015). Eight-year trends in the use of opioids, other analgesics, and psychotropic medications among institutionalized older people in Finland. Journal of the American Medical Directors Association, 10, 009. doi: 10. 1016/j. jamda. 2015. 06. 009.
44. Richter, T., Mann, E., Meyer, G., Haastert, B. and Köpke, S. (2012). Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. Journal of the American Medical Directors Association, 13, 187. e187-e187. e113. doi: 10. 1016/j. jamda. 2011. 03. 007.
45. Rolland, Y., Abellan van Kan, G., Hermabessiere, S., Gerard, S., Guyonnet Gillette, S. and Vellas, B. (2009). Descriptive study of nursing home residents from the REHPA network. Journal of Nutrition Health and Aging, 13, 679-683.
46. Schols, J., Crebolder, H. and van Weel, C. (2004). Nursing home and nursing home physician: the Dutch experience. Journal of the American Medical Directors Association, 5, 207-212.
47. Schulze, J., van den Bussche, H., Glaeske, G., Kaduszkiewicz, H., Wiese, B. and Hoffmann, F. (2013). Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances. European Neuropsychopharmacology, 23, 1034-1042. doi: 10. 1016/j. euroneuro. 2013. 02. 001
48. Shah, S., Carey, I., Harris, T., Dewilde, S. and Cook, D. (2011). Antipsychotic prescribing to older people living in care homes and the community in England and Wales. International Journal of Geriatric Psychiatry, 26, 423-434. doi: 10. 1002/gps. 2557. Epub 2010 Sep 27.
49. Sink, K., Holden, K. and Yaffe, K. (2005). Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. Journal of the American Medical Association, 293, 596-608.
50. Steinberg, M. et al. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the cache county study. International Journal of Geriatric Psychiatry, 23, 170-177.
51. Stewart, R. et al. (2014). Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London care home survey. Age Ageing, 43, 562-567. doi: 10. 1093/ageing/afu062.
52. Sturm, H., van Gilst, W., Veeger, N. and Haaijer-Ruskamp, F. (2007). Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey. Pharmacoepidemiology and Drug Safety, 16, 96-103.
53. Testad, I. et al. (2010). Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. International Journal of Geriatric Psychiatry, 25, 725-731. doi: 10. 1002/gps. 2414.
54. Toscani, F. et al. (2013). Treatments and prescriptions in advanced dementia patients residing in long-term care institutions and at home. Journal of Palliative Medicine, 16, 31-37. doi: 10. 1089/jpm. 2012. 0165.
55. Trinh, N.-H., Hoblyn, J., Mohanty, S. and Yaffe, K. (2003). Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. Journal of the American Medical Association, 289, 210-216.
56. Van der Spek, K. et al. (2015). A reliable and valid index was developed to measure appropriate psychotropic drug use in dementia. Journal of Clinical Epidemiology, 68, 903-912. doi: 10. 1016/j. jclinepi. 2015. 03. 012.
57. Volicer, L., van der Steen, J. and Frijters, D. (2013). Involvement in activities and wandering in nursing home residents with cognitive impairment. Alzheimer Disease and Associated Disorders, 27, 272-277. doi: 10. 1097/WAD. 0b013e31826d012e.
58. Wetzels, R., Zuidema, S., de Jonghe, J., Verhey, F. and Koopmans, R. (2010). Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. American Journal of Geriatric Psychiatry, 18, 1054-1065. doi: 10. 1097/JGP. 0b013e3181f60fa1.
59. Wetzels, R., Zuidema, S., de Jonghe, J., Verhey, F. and Koopmans, R. (2011). Prescribing pattern of psychotropic drugs in nursing home residents with dementia. International Psychogeriatrics, 23, 1249-1259. doi: 10. 1017/S1041610211000755.
60. World Health Organization Collaborating Centre for Drug Statistics Methodology. (2015). Anatomical Therapeutic Chemical (ATC) classification system: guidelines for ATC classification and DDD assignment. Available at: http://www. whocc. no/atcddd/; last accessed 1 December 2015.
61. Zuidema, S., van Iersel, M., Koopmans, R., Verhey, F. and Olde Rikkert, M. (2006). Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review. Nederlands Tijdschrift voor Geneeskunde, 150, 1565-1573.
62. Zuidema, S. U. et al. (2015). A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice. International Psychogeriatrics, 27, 1849-1859. doi: 10. 1017/s1041610215000745.
63. Zwijsen, S. et al. (2014). Nurses in distress? An explorative study into the relation between distress and individual neuropsychiatric symptoms of people with dementia in nursing homes. International Journal of Geriatric Psychiatry, 29, 384-391. doi: 10. 1002/gps. 4014.